ArticleThe Journal of biological chemistry2014

Enhanced in vivo efficacy of a type I interferon superagonist with extended plasma half-life in a mouse model of multiple sclerosis.

Daniel Harari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.